Swiss National Bank’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52M | Hold |
164,400
| – | – | ﹤0.01% | 1945 |
|
|
2025
Q1 | $1.41M | Buy |
+164,400
| New | +$1.41M | ﹤0.01% | 1962 |
|
|
2024
Q2 | – | Sell |
-161,500
| Closed | -$822K | – | 2471 |
|
|
2024
Q1 | $822K | Hold |
161,500
| – | – | ﹤0.01% | 2314 |
|
|
2023
Q4 | $1.5M | Sell |
161,500
-16,200
| -9% | -$151K | ﹤0.01% | 2005 |
|
|
2023
Q3 | $1.16M | Buy |
177,700
+4,400
| +3% | +$28.8K | ﹤0.01% | 2155 |
|
|
2023
Q2 | $1.41M | Buy |
173,300
+5,000
| +3% | +$40.7K | ﹤0.01% | 2116 |
|
|
2023
Q1 | $1.44M | Sell |
168,300
-19,900
| -11% | -$171K | ﹤0.01% | 2040 |
|
|
2022
Q4 | $1.74M | Buy |
188,200
+4,600
| +3% | +$42.6K | ﹤0.01% | 1980 |
|
|
2022
Q3 | $1.9M | Buy |
183,600
+4,100
| +2% | +$42.3K | ﹤0.01% | 1908 |
|
|
2022
Q2 | $1.8M | Buy |
179,500
+8,700
| +5% | +$87.1K | ﹤0.01% | 1998 |
|
|
2022
Q1 | $2.1M | Buy |
170,800
+12,600
| +8% | +$155K | ﹤0.01% | 2011 |
|
|
2021
Q4 | $2.74M | Buy |
158,200
+11,600
| +8% | +$201K | ﹤0.01% | 1841 |
|
|
2021
Q3 | $2.63M | Hold |
146,600
| – | – | ﹤0.01% | 1874 |
|
|
2021
Q2 | $3.35M | Buy |
+146,600
| New | +$3.35M | ﹤0.01% | 1768 |
|